Skip to main content
. Author manuscript; available in PMC: 2018 Mar 19.
Published in final edited form as: Cancer Immunol Res. 2017 Oct 15;5(11):1029–1045. doi: 10.1158/2326-6066.CIR-17-0175

Table 1.

Tumor outgrowth mediated by activated immune cells

Culture conditions Rate of outgrowth >104 cells on d7
Explant alone 2/19
Explant + Control Spl/LN 0/7
Explant + Tumor rejected Spl/LN 4/6
Explant + VEGF 0/4
Explant + Control Spl/LN + VEGF 2/5
Explant + Tumor rejected Spl/LN + VEGF 4/4

Abbreviation: LN, lymph node.

*

MRD explants from any of 4 different primary treatments.